NASDAQ: HBIO
Harvard Bioscience Inc Stock Ownership - Who owns Harvard Bioscience?

Insider buying vs selling

Have Harvard Bioscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James W. GreenDirector2025-08-1533,200$0.53
$17.56kSell
James W. GreenDirector2025-08-1511,540$0.53
$6.10kSell
Jennifer CoteChief Financial Officer2025-03-195,687$0.69
$3.92kSell
James W. GreenChief Executive Officer2025-03-1938,413$0.69
$26.47kSell

1 of 1

HBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HBIO insiders and whales buy or sell their stock.

HBIO Shareholders

What type of owners hold Harvard Bioscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Skystone Advisors LLC32.42%14,452,038$8.87MInsider
James W. Green8.72%3,885,380$2.39MInsider
Weber Capital Management LLC7.18%3,200,380$1.97MInstitution
Chane Graziano6.74%3,005,150$1.85MInsider
Hso Limited Partnership6.19%2,757,257$1.69MInsider
Vanguard Group Inc4.31%1,923,275$1.18MInstitution
Acadian Asset Management LLC3.98%1,772,627$1.09MInstitution
David Green3.28%1,460,467$896.73kInsider
Meros Investment Management LP2.73%1,217,628$747.62kInstitution
Corsair Capital Management LP2.49%1,108,692$680.74kInstitution

1 of 3

HBIO vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HBIO35.29%64.71%Net Selling
ZJYL0.26%0.00%
POCI16.60%83.40%Net BuyingNet Buying
FEMY16.10%4.13%Net Buying
MLSS5.75%64.37%Net Selling

Harvard Bioscience Stock Ownership FAQ

Who owns Harvard Bioscience?

Harvard Bioscience (NASDAQ: HBIO) is owned by 39.16% institutional shareholders, 71.83% Harvard Bioscience insiders, and 0.00% retail investors. Skystone Advisors LLC is the largest individual Harvard Bioscience shareholder, owning 14.45M shares representing 32.42% of the company. Skystone Advisors LLC's Harvard Bioscience shares are currently valued at $8.87M.

If you're new to stock investing, here's how to buy Harvard Bioscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.